President Barack Obama and key congressional Democrats want a better deal on prescription drugs sold to seniors. But if they get it, seniors will pay billions of dollars more for their medicines.

Fraud and abuse in America's health care system costs taxpayers hundreds of billions of dollars a year--more than enough to pay for high quality private health insurance for every uninsured American.

Waxman-Markey is a bundle of contradictions.

As the House plans to vote on the legislation, AEI energy and environmental scholars find many problematic elements within the proposed bill, and all note that this legislation consists, at its core, of a cap and trade program for greenhouse gases.

At this AEI event, experts will discuss the future of the CFPA bill in the House and Senate and whether it has the potential to effectively reform the financial system.

Many analysts have written about the innumerable problems with cap-and-trade, and most of the problems that have been predicted have found their way into the current cap-and-trade law working its way through Congress.

The 1984 Hatch-Waxman Act created a streamlined path for generic drugs to reach the market after pioneer drug patents expire. The result has been the most vigorous and competitive generic drug market in the world, but the Hatch-Waxman Act does not apply to most biologics. Isolated from a variety of...

Creating a nationwide health insurance market in which individuals or groups can choose better and less expensive coverage from another state would create real competition and force private insurers in each state to create better products, improve service, and lower prices.